Related Experiment Video
Updated: May 4, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Identification of CD244-expressing myeloid-derived suppressor cells in patients with active tuberculosis
Bingfen Yang1, Xinjing Wang1, Jing Jiang1
1Key Laboratory of Tuberculosis Prevention and Treatment of PLA, Division of Research, Institute of Tuberculosis, 309 Hospital, 17 Hei Shan Hu Road, Haidian, Beijing 100091, China.
Insights
Researchers identified a specific subpopulation of cells, CD3(-)CD244(high) cells, in patients with active tuberculosis (TB). These cells function as myeloid-derived suppressor cells (MDSCs) and may serve as a novel biomarker for TB diagnosis.
Area of Science:
- Immunology
- Cell Biology
- Tuberculosis Research
Background:
- Active tuberculosis (TB) is associated with immune suppression, but the underlying mechanisms are not fully understood.
- Myeloid-derived suppressor cells (MDSCs) are known for their potent immunosuppressive capabilities, impacting both innate and adaptive immunity.
Purpose of the Study:
- To investigate the role of CD244 (2B4)-expressing cells in the peripheral blood mononuclear cells (PBMCs) of patients with active TB.
- To characterize a specific CD3(-)CD244(high) cell subpopulation and assess its potential as a biomarker for active TB.
Main Methods:
- Flow cytometry was used to analyze PBMCs from active TB patients and healthy controls.
- Phenotypic characterization of the CD3(-)CD244(high) cell population was performed using various cell surface markers.
- Expression levels of NOS2 and correlations with T cell activation markers were assessed.
Main Results:
- A distinct CD3(-)CD244(high) cell subpopulation was identified in active TB patients.
- These cells exhibited phenotypes consistent with human myeloid-derived suppressor cells (MDSCs).
- Higher frequencies of CD3(-)CD244(high) cells and elevated NOS2 expression were observed in active TB patients, correlating with reduced T cell activation.
Conclusions:
- The CD3(-)CD244(high) cell population represents a subset of human MDSCs.
- CD244 can potentially serve as a novel marker for identifying human CD3(-)HLA-DR(-)CD11b(int)CD33(+) MDSCs in the context of active TB.
Abstract:
Development of active TB is accompanied by immune suppression and the underlining mechanisms have been explored extensively in recent years. MDSCs are a heterogeneous group of immature and progenitor myeloid cells with strong immunosuppressive ability for both natural and adaptive immunity. In our analysis of CD244 (2B4)-expressing cells in PBMCs from patients with active TB, a CD3(-)CD244(high) subpopulation was identified. A match of cell population in flow cytometry showed that nearly all CD3(-)CD244(high) cells were CD3(-)HLA-DR(-)CD11b(int)CD33(+) cells. The CD3(-)CD244(high) cell population has phenotypes of CD3(-)CD19(-)CD56(-)CD15(-)CD66b(-)CD33(+)CD11b(+)CD14(-)HLA-DR(neg/low), which was consistent with MDSCs in humans as previously reported. Patients with active TB had higher frequencies of CD3(-)CD244(high) cells as compared with healthy controls. The CD3(-)CD244(high) cell population had high levels of NOS2 expression and was negatively correlated with activation and effective molecule production of CD4(+) and CD8(+) T cells. In conclusion, CD3(-)CD244(high) cells had phenotypes of MDSCs and CD244 might be used as a marker for human CD3(-)HLA-DR(-)CD11b(int)CD33(+) MDSCs.
More Related Videos
15:28A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
Published on: January 17, 2014
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...